173 related articles for article (PubMed ID: 3259253)
21. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of neutrophil elastase by alpha-1-proteinase inhibitor oxidized by activated neutrophils.
Padrines M; Schneider-Pozzer M; Bieth JG
Am Rev Respir Dis; 1989 Mar; 139(3):783-90. PubMed ID: 2784294
[TBL] [Abstract][Full Text] [Related]
23. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation.
Llewellyn-Jones CG; Lomas DA; Stockley RA
Thorax; 1994 Jun; 49(6):567-72. PubMed ID: 7912452
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes.
Weiss SJ; Curnutte JT; Regiani S
J Immunol; 1986 Jan; 136(2):636-41. PubMed ID: 3484496
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
[TBL] [Abstract][Full Text] [Related]
26. Reversible inhibition of neutrophil elastase by thiol-modified alpha-1 protease inhibitor.
Tyagi SC
J Biol Chem; 1991 Mar; 266(8):5279-85. PubMed ID: 2002060
[TBL] [Abstract][Full Text] [Related]
27. Enhanced release of elastase and oxidative inactivation of alpha-1-protease inhibitor by stimulated human neutrophils exposed to Pseudomonas aeruginosa pigment 1-hydroxyphenazine.
Ras GJ; Theron AJ; Anderson R; Taylor GW; Wilson R; Cole PJ; van der Merwe CA
J Infect Dis; 1992 Sep; 166(3):568-73. PubMed ID: 1323622
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity.
Morrison HM; Welgus HG; Stockley RA; Burnett D; Campbell EJ
Am J Respir Cell Mol Biol; 1990 Mar; 2(3):263-9. PubMed ID: 2310584
[TBL] [Abstract][Full Text] [Related]
29. Interference of cartilage surface with interaction of granulocyte elastase with alpha 1-proteinase inhibitor. An in vitro model of enzyme inhibition in the joint space.
Burkhardt H; Kasten M; Rauls S; Rehkopf E
Rheumatol Int; 1987; 7(3):133-8. PubMed ID: 3313660
[TBL] [Abstract][Full Text] [Related]
30. Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor.
Bruch M; Bieth JG
Biochem J; 1986 Aug; 238(1):269-73. PubMed ID: 3492198
[TBL] [Abstract][Full Text] [Related]
31. Differences in distribution and synthesis of the functional opponents alpha 1-proteinase inhibitor and neutrophil elastase in eukaryotic cells.
Davids E; Ogilvie A
Histochem Cell Biol; 1995 Sep; 104(3):245-53. PubMed ID: 8542450
[TBL] [Abstract][Full Text] [Related]
32. Chemoattractant activity of Staphylococcus aureus serine proteinase modified human plasma alpha-1-proteinase inhibitor.
Baran K; Górka M; Potempa J; Porwit-Bóbr Z
Antonie Van Leeuwenhoek; 1989 Nov; 56(4):361-5. PubMed ID: 2619289
[TBL] [Abstract][Full Text] [Related]
33. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum.
Hansen G; Schuster A; Zubrod C; Wahn V
Respiration; 1995; 62(3):117-24. PubMed ID: 7569330
[TBL] [Abstract][Full Text] [Related]
34. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils.
Schumacher C; Clark-Lewis I; Baggiolini M; Moser B
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10542-6. PubMed ID: 1438244
[TBL] [Abstract][Full Text] [Related]
35. Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro.
Carp H; Janoff A
J Clin Invest; 1980 Nov; 66(5):987-95. PubMed ID: 6253528
[TBL] [Abstract][Full Text] [Related]
36. Different selectivities of oxidants during oxidation of methionine residues in the alpha-1-proteinase inhibitor.
Maier KL; Matejkova E; Hinze H; Leuschel L; Weber H; Beck-Speier I
FEBS Lett; 1989 Jul; 250(2):221-6. PubMed ID: 2546797
[TBL] [Abstract][Full Text] [Related]
37. Plasmid-liposome transfer of the alpha 1 antitrypsin gene to cystic fibrosis bronchial epithelial cells prevents elastase-induced cell detachment and cytokine release.
Canonico AE; Brigham KL; Carmichael LC; Plitman JD; King GA; Blackwell TR; Christman JW
Am J Respir Cell Mol Biol; 1996 Apr; 14(4):348-55. PubMed ID: 8600939
[TBL] [Abstract][Full Text] [Related]
38. Alpha 1-proteinase inhibitor is more sensitive to inactivation by cigarette smoke than is leukocyte elastase.
Janoff A; Dearing R
Am Rev Respir Dis; 1982 Oct; 126(4):691-4. PubMed ID: 6982012
[TBL] [Abstract][Full Text] [Related]
39. Divergent effects of alpha1-antitrypsin on neutrophil activation, in vitro.
Janciauskiene S; Zelvyte I; Jansson L; Stevens T
Biochem Biophys Res Commun; 2004 Mar; 315(2):288-96. PubMed ID: 14766206
[TBL] [Abstract][Full Text] [Related]
40. Elastase secreted by activated polymorphonuclear leucocytes causes chondrocyte damage and matrix degradation in intact articular cartilage: escape from inactivation by alpha-1-proteinase inhibitor.
Schalkwijk J; van den Berg WB; van de Putte LB; Joosten LA
Br J Exp Pathol; 1987 Feb; 68(1):81-8. PubMed ID: 3493025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
